1-6 of 6
HUSSAIN I. SABA
Close
Sort by
Journal Articles

Combined treatment with lenalidomide and epoetin alfa in lower-risk patients with myelodysplastic syndrome

Clinical Trials & Observations
Rami S. Komrokji, Jeffrey E. Lancet, Arlene S. Swern, Nianhang Chen, Jennifer Paleveda, Richard Lush, Hussain I. Saba, Alan F. List
Journal: Blood
Blood (2012) 120 (17): 3419–3424.
https://doi.org/10.1182/blood-2012-03-415661
Published: 2012
Journal Articles

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Nikhil C. Munshi, M.D., Saem Lee, B.A., Suman Kambhampati, M.D., Abid Mohiuddin, M.D., Michal Rose, M.D., Caroline Behler, M.D., Andrew Han, B.A., Yvonne Efebera, M.D., Antoun Houranieh, RPh., M.S., Ph.D., Mary T. Brophy, M.D., Abraham Zimelman, M.D., Rao H Prabhala, Ph.D., Hussain I. Saba, M.D, Ph.D, Catherine Klein, M.D., Paulette Mehta, M.D, MPH, Teresa Hayes, M.D., David Roodman, M.D, Ph.D, Alan K. Lichtenstein, M.D.
Journal: Blood
Blood (2010) 116 (21): 3061.
https://doi.org/10.1182/blood.V116.21.3061.3061
Published: 2010
Journal Articles

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

Clinical Trials & Observations
Hagop Kantarjian, Yasuhiro Oki, Guillermo Garcia-Manero, Xuelin Huang, Susan O'Brien, Jorge Cortes, Stefan Faderl, Carlos Bueso-Ramos, Farhad Ravandi, Zeev Estrov, Alessandra Ferrajoli, William Wierda, Jianqin Shan, Jan Davis, Francis Giles, Hussain I. Saba, Jean-Pierre J. Issa
Journal: Blood
Blood (2006) 109 (1): 52–57.
https://doi.org/10.1182/blood-2006-05-021162
Published: 2006
Journal Articles

Response Rates of Phase 2 and Phase 3 Trials of Decitabine (DAC) in Patients with Myelodysplastic Syndromes (MDS).

Hussain I. Saba, MD, PhD, Michael Lübbert, MD, PhD, P.W. Wijermans, MD
Journal: Blood
Blood (2005) 106 (11): 2515.
https://doi.org/10.1182/blood.V106.11.2515.2515
Published: 2005
Journal Articles

Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar): Presented in part at the American Society of Hematology meeting held in San Diego, CA, December 1997.

Ranjana Advani, Hussain I. Saba, Martin S. Tallman, Jacob M. Rowe, Peter H. Wiernik, Joseph Ramek, Kathleen Dugan, Bert Lum, Jenny Villena, Eric Davis, Elisabeth Paietta, Manuel Litchman, Branimir I. Sikic, Peter L. Greenberg
Journal: Blood
Blood (1999) 93 (3): 787–795.
https://doi.org/10.1182/blood.V93.3.787
Published: 1999
Journal Articles

Anti-Heparin Activity of Lysosomal Cationic Proteins from Polymorphonuclear Leukocytes

HUSSAIN I. SABA, M.D., HAROLD R. ROBERTS, M.D., JOHN C. HERION, M.D.
Journal: Blood
Blood (1968) 31 (3): 369–380.
https://doi.org/10.1182/blood.V31.3.369.369
Published: 1968